GLP-1 (glucagon-like peptide-1) medications, including semaglutide and tirzepatide, are designed to enhance insulin secretion, suppress appetite, and regulate food intake
Stay hydrated and support scalp health Maintaining hydration is vital for overall health and can significantly benefit scalp health as well
They pass via the digestive tract
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
WT:Gnas fl/fl [saline] p = 0.0413
Retatrutide remains an investigational medication and has not received FDA approval